UPDATE: Piper Jaffray Color on MAKO Surgical PT Increase

Piper Jaffray, which raised its PT on shares of MAKO Surgical MAKO, is providing some color on the stock. “Our survey of current MAKO customers indicates that the surgical preference evaluation group is expanding to a wider group of sites and surgeons, and interest among other customers is on the rise – both of which have positive implications for our 2012 estimates for hips and robot revenues,” Piper Jaffray writes. “We expect MAKO to finish Q2 with 7 centers performing hips, and expect the company to add to that number in July and August before the commercial launch of the system in 2H11.” MAKO Surgical closed Tuesday at $31.77.